"Does anyone else find it odd that $200 billion is spend on cancer research every single year…and the only thing to show for it is a 75% increase in cancer death since the 1990’s?"
I compiled 100 linked, annotated sources, including clinical trials showing
measurable benefits from cancer prevention and treatment.
One qualification matters: the approximately 75% figure resembles a real global
increase in total deaths from 1990–2023: 74.3%. But that study also reports declining
age-standardized mortality. More deaths in a larger, older population does not
demonstrate that research accomplished nothing.
For your requested mid-1990s comparison, the recorded U.S. numbers are:
| Measure | Annual cancer deaths |
|---|---|
| Actual 1995 toll | 538,455 |
| Actual 2024 toll | 619,876 |
| What a 75% increase from 1995 would mean | 942,296 |
The first two figures come from final CDC/NCHS mortality reports. 2024 is the latest
complete year available—not an estimate for 2026.
The arithmetic:
538,455619,876−538,455×100=15.12%A 75% increase would therefore mean approximately 322,420 more annual U.S. deaths
than actually recorded. That gap is arithmetic—not itself an estimate of lives saved.
Meanwhile, the age-adjusted cancer death rate fell from 211.7 to 139.4 per 100,000,
approximately 34% lower.
The spending claim also needs a source. NCI’s $208.9 billion figure concerns projected
cancer medical care costs, including services and prescriptions—not research spending.
Its FY2026 appropriation is $7.35 billion, although that is only one component of
worldwide research funding.
And “nothing to show for it” contradicts the evidence: ACS estimates 4.8 million U.S.
cancer deaths averted since 1991, reflecting reduced smoking, earlier detection, and
improved treatment. The report documents specific advances without pretending every cancer has improved equally.
No comments:
Post a Comment